Report Details:
15 Companies Covered
200 Pages
Market Research Future (MRFR) has published a cooked research report on the “Blood Testing Market” that contains information from 2018 to 2035.
The Blood Testing Market is estimated to register a CAGR of 7.15% during the forecast period of 2025 to 2035.
MRFR recognizes the following companies as the key players in the Global Blood Testing Market — Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson & Co., Hologic Inc., Mindray, Thermo Fisher Scientific, Danaher, Roche, Sysmex, Ortho Clinical Diagnostics, Grifols, Beckman Coulter, and Siemens Healthineers.
Blood Testing Market Highlights
The Blood Testing Market is accounted for to register a CAGR of 7.15% during the forecast period and is estimated to reach 236.23 USD Billion by 2035.
The Blood Testing Market is poised for substantial expansion, projected to grow from 110.49 USD Billion in 2024 to 236.23 USD Billion by 2035, registering a robust CAGR of 7.15% during the forecast period (2025–2035). This growth is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and infectious conditions, alongside the increasing demand for early diagnosis and preventive healthcare. Advancements in diagnostic technologies, particularly point-of-care testing and laboratory automation, are significantly improving testing accuracy, speed, and accessibility, further fueling market growth.
The integration of artificial intelligence (AI) and machine learning (ML) in blood testing workflows is streamlining diagnostic interpretation and reducing turnaround time, making testing more efficient across hospitals, clinics, and laboratories. Additionally, the post-pandemic surge in home-based and telehealth diagnostics has accelerated the adoption of remote blood testing kits and self-collection solutions, supporting patient-centric healthcare models.
Segment-wise, the Complete Blood Count (CBC) test remains the most widely used diagnostic category, valued at 5.76 USD Billion in 2024 and projected to reach 9.15 USD Billion by 2035. Hospitals and diagnostic laboratories currently dominate market share due to their comprehensive testing infrastructure, though point-of-care and home care segments are witnessing the fastest growth.
Regionally, North America leads the Global Blood Testing Market, supported by advanced healthcare infrastructure, higher diagnostic awareness, and strong R&D investment. Europe follows, driven by its growing geriatric population and healthcare innovation, while Asia-Pacific emerges as the fastest-growing region, fueled by healthcare expansion, a large patient base, and increasing adoption of advanced diagnostic tools in countries such as China and India.
Segment Analysis
The Global Blood Testing Market has been segmented based on Test Type and End User.
By Test Type, the market includes Complete Blood Count (CBC), Blood Chemistry Tests, Blood Glucose Tests, Coagulation Tests, and Blood Typing Tests. The CBC segment held the largest market share in 2024, while Blood Chemistry Tests and Blood Glucose Tests are projected to witness robust growth during the forecast period.
By End User, the hospitals and diagnostic laboratories segment dominates the market, whereas home care and point-of-care testing are emerging as the fastest-growing segments due to increased self-testing adoption.
Region Analysis
By Region, the Blood Testing Market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America holds the largest market share owing to advanced healthcare infrastructure and high diagnostic expenditure. Europe follows closely, driven by its aging population and expanding healthcare access. The Asia-Pacific region is anticipated to register the fastest growth rate due to the rising patient pool, healthcare investments, and adoption of innovative diagnostic technologies in China and India.
Key Findings of the Study
- The Global Blood Testing Market is expected to reach 236.23 USD Billion by 2035, at a CAGR of 7.15% during the forecast period.
- North America accounted for the largest market share, while Asia-Pacific is the fastest-growing region.
- Based on Test Type, the CBC segment dominated the market in 2024.
- Hospitals and diagnostic laboratories are the leading end users, with home-based testing witnessing rapid adoption.
- Key players include Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson & Co., Roche, Thermo Fisher Scientific, and Siemens Healthineers.
Related Reports
https://www.marketresearchfuture.com/reports/blood-testing-market-5797